Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001

Internal Medicine Journal

Volumn 35, Issue 3, 2005, Pages 170-173

  Lynn, S J ^a   Sawyers, S M ^a   Moller, P W ^a   O'Donnell, J L ^a   Chapman, Peter T ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Idiopathic inflammatory myopathies; Malignancy; Overlap syndrome

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE;

ADULT; ADULT ONSET INFLAMMATORY MYOPATHY; ELECTROMYOGRAPHY; EXPERIENCE; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MUSCLE BIOPSY; MYOSITIS; NEW ZEALAND; ONSET AGE; PRIORITY JOURNAL; RELAPSE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; REVIEW;

AGED; BIOPSY; DIAGNOSTIC ERRORS; DRUG THERAPY, COMBINATION; ELECTROMYOGRAPHY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MEDICAL AUDIT; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; NEW ZEALAND; PATIENT DISCHARGE; PREDNISONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 15244347185     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2004.00764.x     Document Type: Review

References (21)

1. Engel AG, Hohlfeld R, Barker BQ. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology, 2nd edn. New York: McGraw-Hill; 1994; 1335-83.
2. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin North Am 2002; 28: 723-41.
3. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991; 325: 1487-98.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 403-7.
5. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 2002; 28: 723-41.
6. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve 2002; 25: 332-47.
7. Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 2002; 28: 779-98.
8. Reimers CD, Schedel H, Fleckenstein JL, Naegele M, Witt TN, Pongratz DE et al. Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults. J Neurol 1994; 241: 306-14.
9. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. Ann Intern Med 2001; 134: 1087-95.
10. Hill CL, Zhaug Y, Sigurgeirsson B, Pukkala E, Mellenkjaer L, Airio A et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357: 96-100.
11. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992; 326: 363-7.
12. Callen JP. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol 2002; 138: 969-71.
13. Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis. Arch Dermatol 2002; 138: 885-90.
14. Mastalgia FL, Phillips BA, Zilko P. Treatment of inflammatory myopathies. Muscle Nerve 1997; 20: 651-64.
15. Mastalgia FL. Treatment of autoimmune inflammatory myopathies. Curr Opin Neurol 2000; 13: 507-9.
16. Villalba L, Hicks JE, Adam EM, Sherman JB, Gourley MF, Leff RL et al. Treatment of refractory myositis. A randomised crossover study of two new cytotoxic regimens. Arthritis Rheum 1998; 41: 392-9.
17. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993; 329: 1993-2000.
18. Dalakas MC. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis and polymyositis. Neurology 1998; 51: 537-45.
19. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996; 14: 263-74.
20. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 2002; 41: 22-6.
21. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B et al. Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors of prognosis. J Rheumatol 2001; 28: 2230-7.